drugset / Trial / NCT00955994

Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome

NCT00955994 ↗

Phase 2 Completed 100 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

The treatment of acute pain in patients with irritable bowel symptoms is suboptimal. This is a placebo controlled study of the on demand treatment of pain experienced over a 4 week period in patients with irritable bowel syndrome. Patients will record the severity of pain when they take the study medication and two hours later.

Timeline

Start
2005-01
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Asimadoline Small molecule 0.5 mg —